Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePhase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.AuthorsAshkar, Ryan; Feldman, Darren R.; Adra, Nabil; Zaid, Mohammad Abu; Funt, Samuel A.; Althouse, Sandra K.; Perkins, Susan M.; Snow, Christin I.; Lazzara, Kayla M.; Sego, Lina M.; Quinn, David I.; Hanna, Nasser H.; Einhorn, Lawrence H.; Albany, CostantinePublicationInvestigational New Drugs, 2021, Vol 39, Issue 6, p1656ISSN0167-6997Publication typeArticleDOI10.1007/s10637-021-01134-1